Search
-
NewBCN HEALTH presents three communications at the ISPOR Europe congress in Vienna from 6 to ...
BCN HEALTH presents the poster "Hospital care and medical costs of septic arthritis in Spain: a retrospective multicentre analysis"
-
NewInnovation Hallmark 'Barcelona Science Park'
2021 was a key year for the consolidation of PCB community companies’ ability to attract private investment and other sources of funding
-
NewÅKRN is now ISO 9001 quality certified
AKRN, now part of NAMSA, is now ISO 9001:2015 quality certified by EQA, a recognized Spanish accredited certification body
-
NewNORAYBIO celebra su 20 aniversario como empresa de referencia para el sector de las biocie...
La empresa, que celebra su aniversario el 21 de octubre, continúa su expansión internacional gracias a la innovación en sus productos software para la gestión de investigaciones científicas
-
NewWhy we need to stop stigmatising mental illnesses: "They should also be researched and tre...
On the occasion of World Mental Health Day this Monday, we talk to Carlos Buesa, CEO of Oryzon, a company dedicated to finding solutions for schizophrenia and borderline personality disorder.
-
NewMarc Güell wins the Spanish National Research Award for Young People 2022
Dr Marc Güell has received the Ángela Ruiz Robles 2022 National Research Award for Young People, in the field of technology transfer, awarded by the Ministry of Science and Innovation of Spain
-
NewDiabetic patients in rural areas will be able to be diagnosed with diabetic retinopathy in...
Diabetic retinopathy is the leading cause of low vision in adults between 50 and 70 years of age in the Western world
-
NewEuronext abre el plazo para participar a su 8ª edición de Techshare
CDuring the six-month training programme structured around several main complementary modules, participants will discover the roadmap towards an IPO
-
NewOLIGOFASTX consortium shares at Farmaforum the progress of the project after 1 year of wor...
They have organized the round table "End-to-end technological solution for the development of oligonucleotide-based therapies"
-
NewFlomics Biotech amongst the best 20 startups to participate in Decelera Menorca Program
lomics Biotech was selected and participated last week in the highly competitive Decelera Menorca startup program
-
NewBIOLAN HEALTH, in collaboration with HOSPITAL QUIRÓNSALUD BIZKAIA, launches in the Basque ...
Lactose intolerance affects 20% of our population
-
NewAtlas Molecular Pharma (Derio), has received FDA approval to initiate clinical development...
Atlas Molecular Pharma (Derio), a company dedicated to the identification and development of novel pharmacological chaperones through a proprietary platform, has received FDA approval to initiate
-
NewFundación Cris y Merck lanzaron la campaña #UrgenciaParaLaCiencia con el objetivo de promo...
Esta campaña pretendía visibilizar el impacto positivo que tiene la investigación a la hora de mejorar la vida de las personas con cáncer
-
NewAlmirall: Lebrikizumab cada cuatro semanas mantiene un aclaramiento duradero de la piel en...
Almirall ha anunciado recientemente nuevos resultados completos de los estudios de fase 3 en monoterapia para la dermatitis atópica (DA)
-
NewBTI Biotechnology Institute, galardonada por CEDE con el Premio a la Investigación
BTI Biotechnology Institute, ha sido galardonada por la Fundación CEDE-Confederación Española de Directivos y Ejecutivos con el Premio a la Investigación “en reconocimiento a su importancia en el
-
NewORYZON to give updates on corporate progress in October
Chardan's 6th Annual Genetic Medicines Conference, MSD European Business Development Outreach, Iberian Digital Forum, AACR Special Conference: Cancer Epigenomics, Brain Innovation Days, HealthTech
-
New3P Biopharmaceuticals entrega el premio al mejor Trabajo Fin de Master (TFM)
En el cierre de la quinta edición del Máster en Diseño Galénico y Fabricación en la Industria Farmacéutica de la Universidad de Navarra
-
NewBiorizon Biotech, soluciones con propiedades excepcionales para la nueva agricultura soste...
La visión de Biorizon Biotech sobre la futura agricultura pasa por la importancia que tendrá la agricultura sostenible en los próximos años
-
NewNew approach of Peaches Biotech for the treatment of cytokine storm associated with infect...
Peaches Biotech's Chief Scientific Director publishes positive results for his research against the cytokine storm, a pathology associated with infectious processes in the book “Purinergic System”
-
NewBCN HEALTH publishes a study evaluating the use of resources and medical costs of septic a...
BCN HEALTH has published the study ‘Hospital care and medical costs of septic arthritis in Spain: a retrospective multicenter analysis’ in the journal ‘Journal of Medical Economics’
-
NewNanoligent raised €2.8 M and completed Seed round financing with support of i&i Biotech Fu...
The spin-off of the Universitat Autònoma de Barcelona and the Institut de Recerca de l'Hospital de Santa Creu i Sant Pau specialises in the development of nanotechnology-based cancer treatments